| 摘要 |
The invention relates to novel heterocyclic compounds of the formula (I), in which all of the variables are as defined in the specification, in free form or in salt form, to their preparation, to their use as medicaments and to medicaments comprising them. The compounds (I) are antagonists of VRl receptors.
|
